LT4035B - Novel bicyclic amino-substituted compounds, process for their preparation and pharmaceutical preparation - Google Patents

Novel bicyclic amino-substituted compounds, process for their preparation and pharmaceutical preparation Download PDF

Info

Publication number
LT4035B
LT4035B LTIP1733A LTIP1733A LT4035B LT 4035 B LT4035 B LT 4035B LT IP1733 A LTIP1733 A LT IP1733A LT IP1733 A LTIP1733 A LT IP1733A LT 4035 B LT4035 B LT 4035B
Authority
LT
Lithuania
Prior art keywords
enantiomer
alkyl
treatment
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
LTIP1733A
Other languages
English (en)
Lithuanian (lt)
Inventor
Uli Alf Hacksell
Sven-Erik Hillver
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LTIP1733A publication Critical patent/LTIP1733A/xx
Publication of LT4035B publication Critical patent/LT4035B/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/515—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an acetalised, ketalised hemi-acetalised, or hemi-ketalised hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
LTIP1733A 1989-12-07 1993-12-30 Novel bicyclic amino-substituted compounds, process for their preparation and pharmaceutical preparation LT4035B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8904127A SE8904127D0 (sv) 1989-12-07 1989-12-07 New biocyclic amino-substituted compounds

Publications (2)

Publication Number Publication Date
LTIP1733A LTIP1733A (en) 1995-08-25
LT4035B true LT4035B (en) 1996-09-25

Family

ID=20377709

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1733A LT4035B (en) 1989-12-07 1993-12-30 Novel bicyclic amino-substituted compounds, process for their preparation and pharmaceutical preparation

Country Status (18)

Country Link
US (1) US5376687A (no)
EP (1) EP0457883B1 (no)
JP (1) JPH04503819A (no)
KR (1) KR920701122A (no)
AT (1) ATE137490T1 (no)
AU (1) AU639742B2 (no)
CA (1) CA2046292A1 (no)
DE (1) DE69026816T2 (no)
DK (1) DK0457883T3 (no)
ES (1) ES2086528T3 (no)
FI (1) FI913713A0 (no)
GR (1) GR3020122T3 (no)
LT (1) LT4035B (no)
LV (1) LV10607B (no)
NO (1) NO176018C (no)
RU (1) RU2086537C1 (no)
SE (1) SE8904127D0 (no)
WO (1) WO1991009006A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
IT1278045B1 (it) * 1995-03-09 1997-11-17 Sigma Tau Ind Farmaceuti Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di
US5646188A (en) * 1995-07-05 1997-07-08 Teva Pharmaceutical Industries, Ltd. Polyamine derivatives of 1-aminoindan
US5807897A (en) * 1996-03-01 1998-09-15 Zeneca Limited Aminotetralin derivative and compositions and method of use thereof
US6498196B1 (en) 1998-12-22 2002-12-24 Edward Roberts Compounds useful in pain management
AU3092800A (en) * 1998-12-22 2000-07-12 Astra Pharma Inc. Novel thio-aminotetralin compounds useful in pain management
US6844368B1 (en) 1998-12-22 2005-01-18 Edward Roberts Compounds useful in pain management
US20050032873A1 (en) * 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
WO2007088450A2 (en) * 2006-02-01 2007-08-09 Pfizer Products Inc. Chromane antagonist of the h-3 receptor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222996A2 (de) 1985-09-03 1987-05-27 Ciba-Geigy Ag 3-Amino-dihydro-[1]-benzopyrane und Benzothiopyrane

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803582A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
CA1331191C (en) * 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
CA1335591C (en) * 1988-05-23 1995-05-16 James Arthur Nixon Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
CA2026775C (en) * 1989-01-09 1998-04-07 Per Arvid Emil Carlsson Halo substituted aminotetralins
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
ES2123500T3 (es) * 1989-05-31 1999-01-16 Upjohn Co Derivados de 8-heterociclil-2-aminotetralina activos sobre el sistema nervioso central.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0222996A2 (de) 1985-09-03 1987-05-27 Ciba-Geigy Ag 3-Amino-dihydro-[1]-benzopyrane und Benzothiopyrane

Also Published As

Publication number Publication date
NO176018B (no) 1994-10-10
LTIP1733A (en) 1995-08-25
CA2046292A1 (en) 1991-06-08
SE8904127D0 (sv) 1989-12-07
KR920701122A (ko) 1992-08-11
EP0457883B1 (en) 1996-05-01
WO1991009006A1 (en) 1991-06-27
LV10607B (en) 1995-12-20
LV10607A (lv) 1995-04-20
EP0457883A1 (en) 1991-11-27
FI913713A0 (fi) 1991-08-05
DE69026816D1 (de) 1996-06-05
GR3020122T3 (en) 1996-08-31
AU6958791A (en) 1991-07-18
JPH04503819A (ja) 1992-07-09
DK0457883T3 (da) 1996-08-26
NO913023L (no) 1991-08-02
DE69026816T2 (de) 1996-10-02
ATE137490T1 (de) 1996-05-15
RU2086537C1 (ru) 1997-08-10
NO176018C (no) 1995-01-18
AU639742B2 (en) 1993-08-05
NO913023D0 (no) 1991-08-02
US5376687A (en) 1994-12-27
ES2086528T3 (es) 1996-07-01

Similar Documents

Publication Publication Date Title
CA2455296C (en) 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors
LT4035B (en) Novel bicyclic amino-substituted compounds, process for their preparation and pharmaceutical preparation
FR2548666A1 (fr) Nouveaux derives du nor-tropane et du granatane, leur procede de preparation et leur application en therapeutique
LT3966B (en) Novel 8-substituted-2-aminotetralines, process for preparing thereof, pharmaceutical composition
FI101301B (fi) Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahyd roatsepiinijohdannaisten valmistamiseksi
CZ279745B6 (cs) Stereochemicky čistý derivát 2-hydroxycyklopentylamidu ergolinu, jeho použití, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
FR2534921A1 (fr) Composes amino heterocycliques et procedes pour leur preparation
EP0351255A2 (fr) Dérivés de [(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique
US5173502A (en) Substituted trifluoropropan-1-yl-imidazole alpha 2-receptor anagonists
KOJIMA et al. Syntheses of (±)-2-[(inden-7-yloxy) methyl] morpholine hydrochloride (YM-08054, indeloxazine hydrochloride) and its derivatives with potential cerebral-activating and antidepressive properties
US5149714A (en) Antidepressants
HU220383B (hu) Morfolinszármazékok és az ezeket tartalmazó gyógyászati készítmények
FR2693722A1 (fr) Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
Miller et al. Optically active catecholimidazolines: a study of steric interactions at. alpha.-adrenoreceptors
EP0322391B1 (en) New phenylalkylamine derivatives
EP0351283A1 (fr) Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique
US5194450A (en) Anti-hypertensive sulfonanilides
FR2717803A1 (fr) Dérivés substitués d'hétérocycles azotés et leurs isomères, actifs sur le système nerveux central, procédé d'obtention et compositions pharmaceutiques les contenant.
IE902313A1 (en) 2-amino-1,2,3,4-tetrahydronaphthalene derivatives with¹cardiovascular activity, process for their preparation and¹pharmaceutical compositions containing them
GB2085008A (en) 1,5-bis-(2,3-dihydro-1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application
US3337623A (en) Cyanamide derivatives of tetrahydrodibenzo[a, d]cyclooctene
IE48224B1 (en) Pharmacologically active 1,3-benzodioxin derivatives
JPH01117862A (ja) ５−フエニル−１，２，３ａ，４，５，９ｂ−ヘキサヒドロ−３Ｈ−ベンゾ〔ｅ〕インドール、その製法及び医薬としての用途
NO177901B (no) Substituerte 2-aminotetraliner og fremgangsmåte for deres fremstilling
CH593955A5 (en) 1-(3-Trifluoromethylphenyl)-2-(homo)morpholinopropanes - with anorectic activity

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19971230